BioCentury
ARTICLE | Clinical News

NovoThirteen catridecacog regulatory update

May 28, 2012 7:00 AM UTC

EMA's CHMP issued a positive opinion recommending approval of NovoThirteen catridecacog from Novo Nordisk to treat congenital Factor XIII deficiency, a bleeding disorder. Earlier this year, Novo Nordi...